Drugs

Division of Supply Chain Integrity

Division of Supply Chain Integrity Mission: To reduce threats to the global drug supply chain through increased transparency and accountability, effective enforcement, and promotion of proactive industry vigilance and voluntary compliance.

Division of Supply Chain Integrity’s two primary goals include:

  • Reducing the likelihood that unsafe, ineffective, and poor quality drugs will enter the supply chain and reach consumers; and
  • Raising public awareness of drug security threats and vulnerabilities in the supply chain.

On this page:


News and Events

More News & Events


Counterfeit/Unapproved Drugs in U.S. Distribution


 Internet Drug Outlets/Fraudulent Internet Pharmacies


 Prescription Drug Marketing Act (PDMA) (Wholesale Drug Distributors/Prescription Drug Samples)


We have an electronic mailbox for PDMA reports which we encourage you to use: PDMAREPORTS@fda.hhs.gov.

If you would prefer to mail your reports, please use the following address:

Food and Drug Administration
Center for Drug Evaluation and Research
Office of Compliance
White Oak Building 51, PDMA Reports Mailbox
10903 New Hampshire Avenue
Silver Spring, MD  20993 


Cargo Theft/Diversion


Intentional Adulteration

Contact Us:
Supply Chain issues related to drugs and components:
DrugSupplyChainIntegrity@fda.hhs.gov

Track and Trace:
Drug.trackandtrace@fda.hhs.gov

Report suspected criminal activity:
Inspections, Compliance, Enforcement, and Criminal Investigations

Office of Drug Security, Integrity, and Response
(301) 796-3130

Return to Main Page: Office of Drug Security, Integrity, and Response


 

 

Page Last Updated: 09/15/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.